Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

Summary

This phase IV trial studies how well serial magnetic resonance imaging (MRI) after radiation therapy works in predicting radiation-induced changes in the normal tissue of patients with oral cavity or skull base tumors. Performing MRIs after radiation therapy for patients with oral cavity or skull base tumors may help to predict osteoradionecrosis (a change in non-cancerous tissue).

Eligibility

Inclusion Criteria:

All Cohorts:

* Patients older than 18 years of age
* Patients with good performance status (ECOG score 0-2)
* Patients willing to give written informed consent.

Cohort 1 (Individuals without ORN or MRONJ):

* Patients with histologically proven malignant neoplasms of the oral cavity, oropharynx or skull base.
* Patients currently dispositioned to treatment with radiotherapy and/or antiresorptive or antiangiogenic medication therapy

Cohort 2 (Individuals with ORN or MRONJ):

* Patients with a clinical diagnosis of ORN or MRONJ following treatment for cancer
* Patients previously dispositioned to treatment with radiotherapy and/or antiresorptive or antiangiogenic medication therapy

Exclusion Criteria:

* Patients unable to tolerate DW-MRI or DCE-MRI or having an estimated GFR \< 30ml/min/1.73m2.
* Patients with contraindication to MRI (e.g. non-MRI compatible metallic implants)

Conditions4

Locations1 site

Browse More Trials